HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature.

Abstract
A 49-year-old man diagnosed with hairy cell leukemia (HCL) achieved a complete remission lasting 4 years after treatment with cladrabine and subsequently developed acute myeloid leukemia. Although a wide variety of second malignancies have been noted in HCL with an incidence of 8.7%, acute myeloid leukemia (AML) has been reported only once previously in a splenectomized patient who had been treated with alpha interferon.
AuthorsF Al-Fiar, J Meharchand, J Curtis, J H Lipton
JournalLeukemia research (Leuk Res) Vol. 23 Issue 8 Pg. 719-21 (Aug 1999) ISSN: 0145-2126 [Print] England
PMID10456669 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antineoplastic Agents
  • Interferon-alpha
  • Cladribine
Topics
  • Acute Disease
  • Antineoplastic Agents (therapeutic use)
  • Cladribine (therapeutic use)
  • Humans
  • Interferon-alpha (therapeutic use)
  • Leukemia, Hairy Cell (drug therapy)
  • Leukemia, Myeloid (chemically induced, therapy)
  • Male
  • Middle Aged
  • Neoplasms, Second Primary (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: